Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» asthma
asthma
GSK's long-acting asthma drug halved attacks in phase 3, backing up blockbuster hopes
Fierce Biotech
Mon, 09/9/24 - 11:14 am
GSK
asthma
clinical trials
depemokimab
Sanofi reports positive data from Phase II asthma treatment trial
Clinical Trials Arena
Thu, 05/23/24 - 10:58 am
Sanofi
clinical trials
rilzabrutinib
asthma
Blackstone unearths Uniquity Bio with $300M to explore Merck drug's I&I potential
Fierce Biotech
Wed, 05/15/24 - 11:21 am
Blackstone Life Sciences
Uniquity Bio
solrikitug
COPD
asthma
Senator Maggie Hassan Blasts GSK for Discontinuing Common Children’s Asthma Inhaler to Dodge Price Cap
Xtalks
Tue, 05/7/24 - 06:29 pm
GSK
Senate
asthma
pediatric
drug pricing
Flovent
GSK joins AstraZeneca, Boehringer in capping US out-of-pocket inhaler prices at $35 per month
Fierce Pharma
Thu, 03/21/24 - 06:37 pm
GSK
Boehringer Ingelheim
AstraZeneca
drug pricing
COPD
asthma
RAPT Therapeutics Shares Plunge Premarket on FDA Study Hold
Morningstar
Tue, 02/20/24 - 11:17 am
RAPT Therapeutics
clinical trials
FDA
zelnecirnon
asthma
atopic dermatits
Discontinued GSK asthma drug stirs frustrations
Beckers Hospital Review
Wed, 02/14/24 - 06:36 pm
GSK
asthma
Flovent
GSK Puts $1.4B on the Line in Aiolos Acquisition to Boost Asthma Pipeline
BioSpace
Tue, 01/9/24 - 09:50 am
GSK
Aiolos Bio
M&A
asthma
JPMHC 2024
Connect Biopharma plots phase 3 regulatory path after asthma asset hits mid-stage trial goals
Fierce Biotech
Tue, 12/12/23 - 11:21 am
Connect Biopharma
asthma
clinical trials
rademikibart
Aiolos Bio launches with ex-Gyroscope CEO at the helm, nearly $250M to advance severe asthma med
Fierce Biotech
Tue, 10/24/23 - 09:48 am
Aiolos Bio
funding
asthma
severe asthma
Apogee Files for IPO with Promising Preclinical Immuno Asset
BioSpace
Sun, 06/25/23 - 09:37 pm
Paragon Therapeutics
IPOs
asthma
atopic dermatitis
Pieris stock deflates as AstraZeneca stops trials of asthma drug in response to toxicology signal
Fierce Biotech
Wed, 06/21/23 - 10:54 am
AstraZeneca
Pieris
clinical trials
asthma
elarekibep
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
Fierce Pharma
Wed, 03/29/23 - 09:58 am
AstraZeneca
Amgen
Tezspire
UK
NICE
asthma
severe asthma
Dupixent kicks off 2023 as top pharma brand for ad impressions
Medical Devices and Diagnostics Industry
Mon, 02/6/23 - 06:13 pm
Sanofi
Dupixent
asthma
pharma advertising
AstraZeneca and Avillion win approval for new asthma rescue treatment in adults
Endpoints
Wed, 01/11/23 - 10:53 am
AstraZeneca
Avillion
Airsupra
asthma
FDA
Could AstraZeneca's Asthma Drug Candidate Generate Billions?
Motley Fool
Tue, 12/20/22 - 10:44 am
AstraZeneca
asthma
PT027
Yes, no, maybe: FDA panel delivers mixed verdict on AstraZeneca's asthma rescue medication
Fierce Biotech
Wed, 11/9/22 - 10:43 am
AstraZeneca
asthma
PT027
FDA
Sanofi, Regeneron team with Broadway actor for digital severe asthma program
Medical Marketing and Media
Wed, 10/19/22 - 10:54 pm
asthma
severe asthma
Sanofi
Regeneron
pharma marketing
AstraZeneca debuts annoying purple ‘Phil’ creatures, personified asthma eosinophils ‘behaving badly’
Endpoints
Wed, 10/5/22 - 10:35 am
pharma marketing
DTC advertising
AstraZeneca
eosinophilic asthma
asthma
Fasenra
Sanofi’s asthma therapy shows consistent safety profile in Phase III trial
Clinical Trials Arena
Tue, 09/6/22 - 05:06 pm
Sanofi
Dupixent
pediatric
clinical trials
severe asthma
asthma
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »